Skip to main content
English

Suche

  1. Home
  2. Suche

Webseiten-Inhalte

Potential biomarker for the development of long COVID identified ... contribution to a better understanding of the consequences of COVID-19. Importantly, they may point to another possible cause of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Within this study, the research groups led by Winfried Pickl and Rudolf Valenta (both from the Center for... https://www.meduniwien.ac.at/web/en/ueber-uns/news/2025/news-in-october-2025/potential-biomarker-for-the-development-of-long-covid-identified/
New biomarker for early prediction of response to CAR-T cell therapy ... Nina Worel (Transfusion Medicine) and Ulrich Jäger (Haematology), in collaboration with Winfried Pickl's team (Institute of Immunology), created the basis for dividing groups of patients into those with a high and those with a low probability of responding to CAR-T cell therapy. "Our study shows how important the nature of the T cells is for CAR-T cell production and that exhausted T cells, which can be found in a considerable proportion of patients, pose a problem for subsequent CAR-T cell therapy," says study leader Winfried Pickl. "Our observations of the mode of action of the differently exhausted... https://www.meduniwien.ac.at/web/en/about-us/news/2023/news-in-january-2023/neuer-biomarker-zur-fruehzeitigen-vorhersage-fuer-das-ansprechen-auf-car-t-zell-therapie/
New biomarker for early prediction of response to CAR-T cell therapy ... Nina Worel (Transfusion Medicine) and Ulrich Jäger (Haematology), in collaboration with Winfried Pickl's team (Institute of Immunology), created the basis for dividing groups of patients into those with a high and those with a low probability of responding to CAR-T cell therapy. "Our study shows how important the nature of the T cells is for CAR-T cell production and that exhausted T cells, which can be found in a considerable proportion of patients, pose a problem for subsequent CAR-T cell therapy," says study leader Winfried Pickl. "Our observations of the mode of action of the differently exhausted... https://www.meduniwien.ac.at/web/en/about-us/news/2023/news-in-january-2023/neuer-biomarker-zur-fruehzeitigen-vorhersage-fuer-das-ansprechen-auf-car-t-zell-therapie/medicine-science/
MMAM 2018 - Moscow Mollecular Allergology Meeting | MedUni Vienna ...All Events We are very glad to announce the 1st Moscow Molecular Allergology Meeting (MMAM 2018) organized by NRC Institute of Immunology FMBA of Russia, Russian Association of Allergology and Clinical Immunology (RAAСI), Medical University of Vienna and International Network of Universities for Molecular Allergology and Immunology (INUNIMAI). The main focus of the MMAM 2018 is the development of new strategies for diagnosis and therapy of allergy as well as population-based investigation of molecular IgE-recognition profiles. Keynote Speakers are Rudolf Valenta (Austria), Marianne van Hage (Sweden), Hans Grönlund (Sweden), Stephen Durham (UK), Sebastian Johnston (UK), Marek Jutel (Poland), Alexander Gabibov (Russia), Natalia Nenasheva, Musa Khaitov (Russia), Winfried Pickl (Austria), Hannes Stockinger (Austria). Registration Registration is free of charge. To participate in the conference, you... https://www.meduniwien.ac.at/web/en/about-us/events/detail/mmam-2018-moscow-mollecular-allergology-meeting/
MMAM 2018 - Moscow Mollecular Allergology Meeting | MedUni Wien ...Alle Events We are very glad to announce the 1st Moscow Molecular Allergology Meeting (MMAM 2018) organized by NRC Institute of Immunology FMBA of Russia, Russian Association of Allergology and Clinical Immunology (RAAСI), Medical University of Vienna and International Network of Universities for Molecular Allergology and Immunology (INUNIMAI). The main focus of the MMAM 2018 is the development of new strategies for diagnosis and therapy of allergy as well as population-based investigation of molecular IgE-recognition profiles. Keynote Speakers are Rudolf Valenta (Austria), Marianne van Hage (Sweden), Hans Grönlund (Sweden), Stephen Durham (UK), Sebastian Johnston (UK), Marek Jutel (Poland), Alexander Gabibov (Russia), Natalia Nenasheva, Musa Khaitov (Russia), Winfried Pickl (Austria), Hannes Stockinger (Austria). Anmeldung Registration is free of charge. To participate in the... https://www.meduniwien.ac.at/web/ueber-uns/events/detail/mmam-2018-moscow-mollecular-allergology-meeting/
Detailsite | MedUni Vienna ... entzündliche Darmerkrankungen. Die aus der immunologischen Grundlagen-Forschung hervorgegangenen Biologika werden immer wichtiger, aber auch die Entwicklung neuer Therapie-Optionen“, sagt Winfried Pickl vom Institut für Immunologie der MedUni Wien anlässlich des Welttags der Immunologie am 29. April 2013.Neben Autoimmunerkrankungen lassen sich, so Pickl, auch bestimmte Krebserkrankungen wie Blut- und Lymphdrüsenkrebserkrankungen, Brustkrebs u.a. mit Biologika wesentlich besser behandeln. Ihre Wirkungsweise liegt dabei in der Neutralisierung von überschüssigen Entzündungsfaktoren (Autoimmunerkrankungen) oder aber in der... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/in-german-welttag-der-immunologie-meduni-wien-forscht-an-zusaetzlichen-therapie-optionen-neben-den-wichtigen-biologika/
News ... Darmerkrankungen. Die aus der immunologischen Grundlagen-Forschung hervorgegangenen Biologika werden immer wichtiger, aber auch die Entwicklung neuer Therapie-Optionen“, sagt Winfried Pickl vom Institut für Immunologie der MedUni Wien anlässlich des Welttags der Immunologie am 29. April 2013.Neben Autoimmunerkrankungen lassen sich, so Pickl, auch bestimmte Krebserkrankungen wie Blut- und Lymphdrüsenkrebserkrankungen, Brustkrebs u.a. mit Biologika wesentlich besser behandeln. Ihre Wirkungsweise liegt dabei in der Neutralisierung von überschüssigen Entzündungsfaktoren (Autoimmunerkrankungen) oder aber in der... https://www.meduniwien.ac.at/web/ueber-uns/news/detail/welttag-der-immunologie-meduni-wien-forscht-an-zusaetzlichen-therapie-optionen-neben-den-wichtigen-biologika/
News ... Weihnachten 2011 promovierte er zum Doktor der Molekularen Biologie am Institut für Immunologie an der Medizinischen Universität Wien ( Abteilung Zelluläre Immunologie und Immunhämatologie, Winfried F. Pickl). Seit 2010 macht Klaus Schmetterer die Facharztausbildung im Fach Immunologie an der Med... https://www.meduniwien.ac.at/web/ueber-uns/news/detail/klaus-schmetterer-erhielt-den-wao-outstanding-junior-abstract-award/
New fast test discriminates between cellular immunity to SARS-CoV-2 after vaccination or infection ... MedUni Vienna's Center for Pathophysiology, Infectiology and Immunology under the leadership of Winfried Pickl and Rudolf Valenta, is based on the memory response of T cells to three different SARS-CoV-2 peptide mixtures. T cells are an important part of the specific cellular immune defense: they... https://www.meduniwien.ac.at/web/en/about-us/news/2022/news-in-july-2022/neuer-test-bestimmt-sars-cov-2-immunitaet-in-nur-48-stunden/medicine-science/
Neuer Test bestimmt SARS-Cov-2-Immunität in nur 48 Stunden ... veröffentlicht. Der am Zentrum für Pathophysiologie, Infektiologie und Immunologie der MedUni Wien von Bernhard Kratzer unter Studienleitung von Winfried Pickl und Rudolf Valenta neu entwickelte Test basiert auf der Gedächtnisantwort von T-Zellen gegenüber drei verschiedenen Peptid-Mischungen von SARS-CoV-2. T... https://www.meduniwien.ac.at/web/ueber-uns/news/2022/news-im-juli-2022/neuer-test-bestimmt-sars-cov-2-immunitaet-in-nur-48-stunden/